472 results on '"Ridnour, Lisa A."'
Search Results
2. Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density
3. A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity
4. Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level
5. Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype
6. NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.
7. NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER-Breast Cancer
8. Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients
9. Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs
10. Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation
11. Thrombospondin-1 Inhibits Endothelial Cell Responses to Nitric Oxide in a cGMP-Dependent Manner
12. Nitric Oxide Regulates Angiogenesis through a Functional Switch Involving Thrombospondin-1
13. Hypoxic Inducible Factor 1 α, Extracellular Signal-Regulated Kinase, and p53 Are Regulated by Distinct Threshold Concentrations of Nitric Oxide
14. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
15. Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells
16. Bromination of Deoxycytidine by Eosinophil Peroxidase: A Mechanism for Mutagenesis by Oxidative Damage of Nucleotide Precursors
17. Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
18. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
19. Autocrine IL-10 functions as a rheostat for M1 macrophage glycolytic commitment by tuning nitric oxide production
20. Biological signaling by small inorganic molecules
21. IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium
22. Abstract 2539: Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces cytokine release via the alternative NFKB2 pathway in triple negative breast cancer cells (TNBC) and modulates neutrophil chemotaxis
23. Supplementary Figure 2 from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
24. Supplementary Figure 1 from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
25. Data from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
26. Supplementary Methods and Materials from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
27. Supplementary Figure Legends 1-2 from S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer
28. Supplementary Data from A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide
29. Supplementary Tables 1 - 2 from NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay
30. Supplementary Methods from Dithiolethiones Inhibit NF-κB Activity via Covalent Modification in Human Estrogen Receptor–Negative Breast Cancer
31. Supplemental Figure S3 from CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
32. Data from NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay
33. Data from Dithiolethiones Inhibit NF-κB Activity via Covalent Modification in Human Estrogen Receptor–Negative Breast Cancer
34. Supplemental Figure Legend from CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
35. Data from CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
36. Supplementary Table 1 from Dithiolethiones Inhibit NF-κB Activity via Covalent Modification in Human Estrogen Receptor–Negative Breast Cancer
37. Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells
38. CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation
39. Signaling and stress: The redox landscape in NOS2 biology
40. Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer
41. New nitrosyl ruthenium complexes with combined activities for multiple cardiovascular disorders
42. The chemical biology of NO that regulates oncogenic signaling and metabolism: NOS2 and its role in inflammatory disease
43. Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways
44. Nitric Oxide and Cancer: An Overview
45. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression
46. Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome.
47. Contributors
48. NO in Cancer—Carcinogenesis, Metastasis, and Therapy
49. Erratum to: Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
50. Abstract 3804: Interferon gamma induces NOS2 and COX2 expression in estrogen receptor negative breast cancer leading to immunosuppressive tumor microenvironment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.